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Countering the double-whammy of zoonotic diseases
Estimates put the number of people dying from endemic zoonoses at more than two million each year. Those affected 
above all belong to the low- and middle-income strata of society who have already been overlooked by both policy-
makers and healthcare providers. Our authors give an overview of the key drivers of zoonoses and show how the One 
Health approach can help to control and prevent zoonotic diseases.
By Lian Thomas, Grace Patterson, Lucy Coyne and Jonathan Rushton
A zoonotic disease (zoonoses) can infect both 
animals and people and be transmitted be-
tween vertebrate animals and people. Of the 
known (approximately 1,400) human patho-
gens 60 per cent have come from diseases that 
were first in animals. This historical trend has 
accelerated recently; of the newly emerging 
diseases in people approximately 75 per cent 
are believed to have come from animals. The 
virus that causes COVID-19, SARS-CoV-2, 
is the most recent example of a pathogen in 
animals then infecting people. 
The magnitude of the problem
COVID-19 emergence has created the world’s 
first true pandemic for a hundred years. We 
are currently experiencing first-hand the 
health and economic burden of a pandemic 
born of a zoonotic ‘spill-over’ event. Zoonot-
ic spill-over, the evolution of a pathogen from 
being wholly adapted to transmission between 
non-human animals to becoming wholly or 
partially adapted to humans, appears to be in-
creasing in frequency. COVID-19, one of the 
most visible examples of zoonotic spill-over 
in recent history, follows the relatively recent 
emergence of Severe Acute Respiratory Syn-
drome (SARS), Middle East Respiratory Syn-
drome (MERS), Nipah virus, ‘Swine Flu’ and 
Highly Pathogenic Avian Influenza (H5N1), 
among others, as illustrated in the timeline on 
opposite page. 
The significance of zoonoses with pandemic 
potential will not be lost on any readers; the 
huge cost in terms of human life and the eco-
nomic shocks wrought by our response to this 
virus have firmly placed the risks of emerg-
ing diseases of zoonotic origin in the front 
and centre of public consciousness. The eco-
nomic costs alone of emergence events are 
substantial, with six major zoonotic outbreaks 
occurring between 1997 and 2006 estimated 
to have had a combined economic burden of 
80 billion US dollars. The final bill from the 
current COVID-19 pandemic will be in the 
trillions of dollars, alongside the significant 
health and mental suffering. In addition to the 
COVID-19 burdens, there are communities 
where other endemic zoonotic diseases that 
circulate constantly in people and their animals 
cause frequent and regular negative impact on 
economics, health, and wellbeing. 
It is estimated that over two million people die 
yearly from endemic zoonoses. Millions more 
suffer from debilitating, chronic conditions that 
reduce their quality of life and their economic 
prospects, and often bring social isolation or 
stigma. The burden of zoonotic disease has 
been described as a ‘double-whammy’ where 
the human health impacts are exacerbated by 
losses suffered within the livestock sector, such 
as reduced productivity, livestock deaths, and 
the costs to farmers to control or treat these 
diseases. The burden of these zoonoses and 
of foodborne illnesses is felt predominately in 
low- and middle income countries (LMICs), 
within communities with least resilience to 
health and economic shocks. Endemic zoono-
ses are highly correlated with poverty by dint 
of their association with close contact between 
humans and livestock, poor sanitation, and in-
adequate access to preventative and curative 
health care. Consequently, these ‘neglected 
diseases’ of ‘neglected populations’ have his-




torically been overlooked by policy-makers 
and healthcare providers alike.
What is driving the emergence of 
zoonotic diseases? 
The chief causes of zoonotic spill-over and 
transmission within populations are many and 
varied; yet key drivers can be identified related 
to the increasing frequency of spill-over events, 
transmission of zoonoses and emergence of an-
timicrobial resistance (AMR) as illustrated in 
the Figure on page 10. We can look at these 
drivers through the lens of our globalised food 
system and highlight aspects of current con-
sumption, marketing and production of our 
food related to accelerating these events. 
Our growing and increasingly urbanised and 
affluent human population is driving an un-
precedented expansion of agricultural pro-
duction, specifically an increasing demand 
for animal-source foods. The location of the 
animal production units needed to meet this 
demand, or of the crop-lands required to pro-
vide feed input to these units, requires large-
scale land use change, potentially encroaching 
into wildlife habitats and increasing the op-
portunities for contact between wildlife and 
humans or domestic livestock. It is estimated 
that between 2019 and 2050, up to one billion 
hectares of land will be newly converted into 
agricultural production. Alterations in vector 
distribution are also driven by other land-use 
changes such as widespread irrigation for rice 
crops, exacerbated by anthropogenic climate 
change (to which agriculture is a major con-
tributor), resulting in increasing transmission 
of vector-borne diseases. Changing land-use 
and rainfall patterns appear to be responsible 
for altering temporal patterns of outbreaks of 
the mosquito-borne Rift-Valley Fever, whilst 
the mosquito vector of chikungunya and den-
gue, Aedes albopictus, has broadened its range 
northward, leading to the recent report of the 
first locally-acquired case of dengue in Italy. 
Inadequate biosecurity practices along value 
chains provide opportunities for incursion of 
novel pathogens into the increasingly highly in-
tensive system within them. Under intensified 
production systems, a high number of often 
genetically homogenous livestock species, or 
farmed-wildlife species, are kept in close prox-
imity, potentially under conditions of physio-
logical and psychological stress within which 
disease transmission between animals can be 
facilitated. Those working closely with these 
animals are at a high risk of acquiring infection 
with newly emerging diseases of animal origin. 
The 1998 emergence of Nipah virus (NiV) in 
the Malaysian peninsula is an example of a vi-
rus arising from a wildlife reservoir (fruit bats) 
coming into contact with domestic livestock, 
through the co-existence of intensive mango 
and intensive pig production. This virus began 
circulating within the pig population and out-
breaks of the virus, causing severe neurological 
disorders and with a 40 per cent fatality rate, 
occurred in workers in direct contact with in-
fected pigs. Bat to human (via contaminated 
fruit) and human to human transmission has 
since been reported in Bangladesh and India. 
Similar co-existence of intensive poultry pro-
duction with large populations of wildfowl 
harbouring Influenza H5N1 led to its emer-
gence in China. 
Intensification of livestock production has 
been historically heavily reliant on the use of 
antimicrobial agents for the prevention and 
control of disease often on a whole-herd/
flock basis and, at sub-therapeutic levels, as 
antimicrobial growth promoters (AGPs). The 
sub-therapeutic use of antimicrobials results in 
selective pressure for resistant bacterial strains 
and agriculture-associated antimicrobial resis-
tance (AMR) is of increasing concern world-
wide, as we are seriously faced with the poten-
tial of a post-antibiotic future. 
The onward processing, marketing and con-
sumption of animal-source foods, both domes-
tic livestock and wild-caught or farmed wild-
life species, can also be responsible for potential 
zoonotic transmission events. It is hypothesised 
that the virus that causes COVID-19 was orig-
inally a pathogen of pangolins, the most ex-
tensively trafficked wild mammal in the world 
today, and the wet market, with its multitude 
of disparate mammalian species, provided the 
ideal environment for adaptive changes result-
ing in the sustained human-to-human trans-
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mission we are now experiencing on a global 
scale. 
The speed of introduction of novel pathogens 
into multiple countries is obviously highly 
correlated with the globalisation of travel and 
trade, as people, foods, animals and objects can 
travel across the world in a day. Our globalised 
supply chains involve food products undergo-
ing processing stages in multiple countries or 
even continents, and in each location being 
exposed to pathogens. The Figure demon-
strates some of the drivers of zoonoses and an-
timicrobial resistance 
What can be done to predict, prevent 
and control zoonoses?
One Health, the concept that the health of 
humans, non-human animals and the environ-
ment is intrinsically linked, encourages us as 
a community to think and act in a multi-sec-
toral, multi-disciplinary way. The concept is 
multifaceted and, at its broadest, can be applied 
as a lens to many of the world’s health and 
environmental problems, but is highly applica-
ble to the control and prevention of zoonotic 
disease. Fewer human health practitioners will 
now say ‘zoo-what?’ when zoonoses are men-
tioned, and there will be no turning away from 
the urgent need to improve our ability to de-
tect and respond to zoonotic spill-over events, 
but a greater degree of One Health thinking 
and acting is necessary to have substantial im-
pact on emerging and endemic zoonoses and 
the ever present threat posed by antimicrobial 
resistance alike. 
Preventing zoonotic spill-over, reducing 
transmission events and mitigating the health 
and economic impacts of these threats require 
a paradigm shift in the way we organise and 
legislate our food systems (see also article on 
page 35) and the structure of our animal and 
human health systems. 
Improved multi-disciplinary training is re-
quired for professionals within human, animal 
and environment health to allow for ease of 
communication between sectors. One Health 
student networks and specific training in One 
Health have sprung up globally in recent years, 
a trend which must be sustained and indeed 
accelerated. While the diagnosis and treat-
ment of zoonotic diseases will be improved 
both through increased awareness by frontline 
workers, it also requires accelerated develop-
ment of appropriate diagnostic tests which 
should be affordable and easy to apply, partic-
ularly in resource-constrained settings. 
There is growing ev-
idence of the need to 
conduct control pro-
grammes for zoono-
ses in a One Health 
manner, targeting 
pathogens in both the 
human and non-hu-
man hosts and the en-
vironment or vector 
species. It is essential 
that healthcare services 
take an integrated ap-
proach, whereby these 
control programmes 
are cross-sectoral and 
instead of being pri-
marily ‘vertical’ pro-
grammes, which focus 
on a single pathogen, 
they encompass a wid-
er range of pathogens. 
This will improve 
the efficiency of pro-
grammes and lead to 
more sustainable out-
comes. Identifying and 
capitalising on synergies, such as between the 
control of zoonotic and non-zoonotic hel-
minth infections through water and sanitation 
(WASH) programmes and mass drug admin-
istration (MDA) programmes, is a first step in 
developing more co-ordinated and cost-effec-
tive control programmes. 
Disease surveillance systems allowing for the 
integration of data from the human, animal 
and environment sectors are an important as-
pect of both early-warning for novel emer-
gence events but also for the prioritisation 
and control of endemic zoonoses, foodborne 
disease and antimicrobial resistance. Ensuring 
interoperability between systems set up for use 
by individual sectors will allow for faster re-
sponse to disease events, facilitate inter-sectoral 
understanding and co-operation and eventual-
ly improved data sharing at international level 
through full engagement with the global health 
security agenda and the international health 
regulations. Models for such integrated systems 
exist, such as the Danish programme for sur-
veillance of antimicrobial consumption and re-
sistance in bacteria from farm animals, food and 
humans (DANMAP). Extensive evaluation of 
such systems, including the legislative and bud-
getary changes necessary to implement them, is 
critical if they are to be replicated across many 
countries. Ensuring that environmental data is 
also integrated into these systems is the next 
crucial step in creating truly ‘One Health’ sys-
tems. Appropriately allocating surveillance re-
sources into the prediction and prevention of 
zoonoses can be improved through the use of 
risk-mapping activities integrating socio-eco-
nomic indicators, land use change, climatic 
data and host density and diversity. 
Undertaking surveillance and control pro-
grammes and improving treatment of zoo-
noses is only one side of the coin. If we are 
to truly mitigate the burden of zoonoses in 
all their forms, we must simultaneously con-
centrate on addressing the underlying drivers. 
As a global community, we have to address 
sustainability of agricultural value chains and 
make health the central focus of our agri-food 
policies, including those relating to land-use 
planning, pharmaceutical use within livestock 
production, biosecurity, irrigation and waste 
management. These changes will also involve 
fundamental shifts in consumer perceptions 
and demands. Structural changes are needed to 
improve access to animal-source foods to those 
whose diets are fundamentally deficient in the 
valuable proteins and micronutrients they pro-
vide, whilst moving many of the world’s more 
developed economies back towards predom-
inantly plant-based diets as recommended by 
the Lancet-EAT Commission. 
Defining prioritities is key
All of the steps above will require strong polit-
ical will to create the enabling environment for 
Interaction between intensification of livestock production, 
zoonoses & antimicrobial resistance
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change, including the provision of adequate 
resources. Methodological prioritisation of 
zoonotic disease is necessary to identify great-
est threats, formulate action plans and justify 
spending. To ensure accurate assess of impacts 
and risk, input is needed from sectors beyond 
animal and human health, including agents in-
volved in environmental health, business, trade 
and government. The US Centre for Disease 
Control (CDC) leads OHZDP (One Health 
Zoonotic Disease Prioritization) workshops 
to help entities prioritise their top zoonotic 
diseases of greatest concern and develop One 
Health oriented plans to address identified dis-
eases. This process brings together representa-
tives from animal, human, and environmental 
health and stakeholders from multiple sectors. 
The process involves five steps: selection of 
stakeholders and zoonoses to be ranked, devel-
opment of 5-8 key criteria, development of a 
single categorical question per criterion, rank-
ing of criteria, and ranking of zoonoses based 
on answers to weighted criteria. This process 
uses qualitative, semi-quantitative and quanti-
tative methods to achieve these ends. 
This tool was developed to meet the needs of 
those working in areas where quantitative data 
on zoonoses are scarce and ties between hu-
man and animal health are underutilised. It also 
facilitates equal input from all invested stake-
holders, accommodates diversity of location, 
scale and purpose, acknowledges data limita-
tions, and is quick to increase action. Since its 
launch in 2014, 25 states, regions and countries 
have conducted an OHZDP alongside CDC 
facilitators. Sixteen of these assessments have 
been conducted in Africa, but none in Europe. 
By using the same methodology in different 
regions, CDC investigators have been able 
to identify common themes, which may help 
inform global research and capacity building 
needs.
Sophisticated metrics for cost-benefit 
analyses
OHZDP is a strong advocacy tool, but alloca-
tion of adequate resources to the prediction, 
prevention and control of zoonoses within a 
world of competing interests also requires ro-
bust economic data on the cost-effectiveness 
or cost-benefit of alternative courses of action. 
Economic evaluation of One Health Inter-
ventions within the surveillance, control and 
response to zoonoses is crucial to develop-
ing a robust ‘Business Case’ for One Health, 
including important discussions regarding 
cost-sharing between human and animal and 
public and private sectors. These evaluations 
require consistent metrics by which the bur-
den of diseases can be measured in both the 
human and non-human populations. Whilst 
metrics are available to measure human health 
outcomes, such as the disability adjusted life 
year (DALY) developed for the global bur-
den of diseases study, quantifying the impacts 
of disease within differing hosts requires more 
sophisticated metrics where impacts from both 
sectors can be measured in an equivalent way. 
Two solutions to this problem have been pro-
posed to date. The Zoonoses-DALY (zDALY) 
transforms economic losses in livestock into an 
‘animal life equivalent’ based upon the time 
taken to recoup that loss in the specific geo-
graphic context. An alternative approach is the 
transformation of human health burden into 
economic terms using the value of statistical 
life (VSL). 
While substantial progress has been made to 
quantify the impacts of some zoonoses and 
foodborne illnesses, considerable gaps remain, 
particularly regarding the burden of disease in 
animal populations, and the impact of AMR 
on both humans and animals. Undertaking 
the robust, systematic collection, analysis and 
dissemination of this data is the founding mis-
sion of the Global Burden of Animal Diseas-
es study (GBADs). This ambitious study will 
be undertaken by a large collaboration of ac-
ademic partners with the support of the Bill 
and Melinda Gates Foundation, UK’s For-
eign, Commonwealth & Development Office 
(FCDO), Australian Centre for International 
Agricultural Research (ACIAR), the equine 
welfare NGO Brooke, World Organization 
for Animal Health (OIE) and the UN Food & 
Agriculture Organization (FAO). 
It is important, however, that further dimen-
sions are integrated into our frameworks, in-
cluding the social dimensions of human and 
animal disease and capturing environmental 
impacts. A full appreciation of the wider im-
pacts of zoonoses is likely needed for the large-
scale transformation of food, health and animal 
health systems which are required to move 
into a more sustainable, safe and food-secure 
world fit for habitation by both nine million 
people and the wide diversity of non-human 
life which our planet sustains. 
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An endemic zoonotic disease is one which circulates at a consistent level within the commu-
nity, being transmitted between animals or through contact with animal-source products and 
humans. Examples include bovine tuberculosis, a bacterial disease of cattle related to the 
agent causing human TB which can infect humans and cause many similar symptoms, bru-
cellosis, a bacterial disease causing malaise, joint and muscle pain and a relapsing fever, and 
neurocysticercosis, a brain infection caused by the intermediate, cyst, stage of the pork tape-
worm, which is a leading cause of acquired epilepsy in regions where the parasite is present.  
Foodborne diseases are those following the ingestion of food contaminated with bacteria, 
viruses, parasites or chemical toxins. World-wide, the majority of foodborne illnesses are 
diarrhoeal diseases caused by agents such as Salmonella spp., Campylobacter spp. and 
Norovirus. 
Vector-borne diseases are those transmitted to humans by the bite of an arthropod vector 
such as ticks, lice, mosquitos and fleas. Some may be transmitted by the vector between hu-
mans, such as Dengue and Malaria, while others may be carried by the vector from animals 
to humans, such as Lyme disease and Rift Valley Fever Virus.
